The infographic urges patients not to ignore symptoms, especially if they have a heart condition, and reassures them that hospitals have safety measures to protect patients from infection with the novel coronavirus.
Featuring articles on deaths due to e-cigarette– or vaping-associated lung injury, apixaban for venous thromboembolism in cancer, the management of coronary disease in patients with advanced kidney disease, health-status outcomes in the ISCHEMIA-CKD trial, and ten weeks to crush the curve.
Additionally, renin–angiotensin–aldosterone system inhibitors in patients with Covid-19, and teasing the immune system to repair the heart; a review article on the care of patients with diabetic retinopathy; a case report of a man with high blood pressure, renal insufficiency, and hematuria; and Perspective articles on clinical and social risk adjustment, on prediction models, and on medical care during the pandemic.
Hazen and colleagues find that gut bacteria play a central role in the conversion of dietary proteins into a compound, phenylacetylglutamine ( PAGln), which not only is associated with future cardiovascular disease risk in humans but also promotes platelet responsiveness and blood clotting potentially via adrenergic receptors, according to mouse models.
From a “Circulation: Heart Failure” Journal study (Feb 25, 2020):
The study shows that wearable sensors coupled with machine learning analytics have predictive accuracy comparable to implanted devices.
We demonstrate that machine learning analytics using data from a wearable sensor can accurately predict hospitalization for heart failure exacerbation…at a median time of 6.5 days before the admission.
Heart failure (HF) is a major public health problem affecting >23 million patients worldwide. Hospitalization costs for HF represent 80% of costs attributed to HF care. Thus, accurate and timely detection of worsening HF could allow for interventions aimed at reducing the risk of HF admission.
Several such approaches have been tested. Tracking of daily weight, as recommended by current HF guidelines, did not lead to reduction of the risk of HF hospitalization, most likely because the weight gain is a contemporaneous or lagging indicator rather than a leading event. Interventions based on intrathoracic impedance monitoring also did not result in reduction of readmission risk. The results suggest that physiological parameters other than weight or intrathoracic impedance in isolation may be needed to detect HF decompensation in a timely manner. In fact, 28% reduction of rehospitalization rates has been shown with interventions based on pulmonary artery hemodynamic monitoring. More recently, in the MultiSENSE study (Multisensor Chronic Evaluation in Ambulatory HF Patients), an algorithm based on physiological data from sensors in the implantable cardiac resynchronization therapy defibrillators, was shown to have 70% sensitivity in predicting the risk of HF hospitalization or outpatient visit with intravenous therapies for worsening of HF.
Taking a statin helps keep your cholesterol levels in check. How can that be?
Dr. Stephen Kopecky explains that some people ask to be put on a statin. That’s because statins, while important and effective, are just one part of the whole heart-healthy picture. When you combine a statin with regular exercise, maintaining a healthy weight, controlling stress, not smoking and eating foods based on the Mediterranean diet, you can improve your heart health.
Dr. Kopecky says if you work in lifestyle changes slowly over time, you’ll be on your way to better heart health.
Statins are drugs that can lower your cholesterol. They work by blocking a substance your body needs to make cholesterol. Statins may also help your body reabsorb cholesterol that has built up in plaques on your artery walls, preventing further blockage in your blood vessels and heart attacks.
Several statins are available for use in the United States. They include:
Sometimes, a statin is combined with another heart health medication. Examples are atorvastatin/amlodipine (Caduet) and simvastatin/ezetimibe (Vytorin).
Increasing evidence suggests that statins do more than just lower bad cholesterol. Research has found that the medicines can safely prevent heart disease in certain adults ages 40 to 75. But the benefits aren’t entirely clear for the elderly. And doctors still want to know more about the side effects of statins.
On the Mayo Clinic Radio program, Dr. Todd Miller, a Mayo Clinic cardiologist, explains how exercise affects the heart. This interview originally aired Feb. 22, 2020. Learn more about exercise and the heart: https://www.mayoclinic.org/healthy-li…
Journal of the American Heart Association study (Feb 17, 2020):
The association between poor overall sleep quality and greater consumption of added sugars observed in the current study aligns with previous findings that intakes of confectionary and sugar‐sweetened beverages were higher in middle‐aged Japanese women reporting poor, compared with good, sleep quality.
Background – Poor sleep increases cardiovascular disease risk, and diet likely contributes to this relationship. However, there are limited epidemiological data on the relationship between measures of sleep quality and habitual dietary patterns. This study examined these associations in a diverse sample of women.
Both short sleep duration and poor sleep quality are associated with the development of obesity, type 2 diabetes mellitus, and cardiovascular disease (CVD), and it is likely that the relationship between sleep and cardiometabolic disease risk is partially mediated by diet.5 Indeed, experimental studies demonstrate that restricting sleep duration leads to increases in energy intake, confirming associations of short sleep with higher energy intakes in observational population‐based studies.